
Summary
The highest incidence of non-Hodgkin’s lymphoma (NHL) is in countries with high human development rates, such as Western Europe, North America and Australia. However, the incidence of NHL in 2012 was estimated at 2.2 / 100,000 (23,801 new cases) and 1.5 / 100,000 (16,597 deaths) in India.
Introduction
Non-Hodgkin’s lymphoma (NHL) is a common type of haematological cancer. Globocan in 2012 has estimated the incidence of non-Hodgkin’s lymphoma (NHL) at 5 / 100,000 (385,741 new cases) and the global mortality rate at 2.5 / 100,000 (199,630 deaths)1 but, the NHL classification has changed several times over the last two decades.
The highest incidence of NHL is in countries with high human development rates, such as Western Europe, North America and Australia. On the other hand, the lowest rates are known in parts of Africa and South Asia2
The Indian NHL burden was estimated at 2.2 / 100,000 (23,801 new cases) and 1.5 / 100,000 (16,597 deaths) in 2012. Within the country, the incidence of NHL is higher in urban areas than in rural areas. As per the Ambillikkai registry, the Tamil Nadu rural parts in southern India have the lowest number of NHL cases in the world. Reports from cancer registries suggest that the incidence of all blood cancers is highest in Delhi (the capital of India), followed by Mumbai and Barsi3.
References
- 1.Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. Published online October 9, 2014:E359-E386. doi:10.1002/ijc.29210
- 2.Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol. 2002;19(3):141-150. doi:10.1385/MO:19:3:141
- 3.Nair R, Arora N, Mallath M. Epidemiology of Non-Hodgkin’s Lymphoma in India. Oncology. 2016;91 Suppl 1:18-25. doi:10.1159/000447577